Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major;Multipl transfüzyon uygulanan β-talasemi majörlü ürdünlü hastalarda hepatit c virüsünün seroprevalansı ve genotiplemesi

Turkish Journal of Hematology

Volumn 28, Issue 1, 2011, Pages 47-51

  Al Sweedan, Suleimman Ahmad ^a   Jaradat, Said ^b   Amer, Khitam ^b   Hayajneh, Wail ^a   Haddad, Hazem ^b  

^a KING ABDULLAH UNIVERSITY HOSPITAL   (Jordan)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Thalassemia; Transfusion; Virology

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; VIRUS RNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JORDAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; PLASMA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SEROPREVALENCE; SPLENECTOMY; THALASSEMIA MAJOR; VIRUS LOAD;

EID: 79953201577     PISSN: 13007777     EISSN: 13085263     Source Type: Journal    
DOI: 10.5152/tjh.2011.05     Document Type: Article

References (23)

1. Sadeghi-Bojd S, Hashemi M, Karimi M. Renal tubular function in patients with β-thalassaemia major in Zahedan, southeast Iran. Singapore Med J 2008;49:410-412.
2. Wanachiwanawin W, Luengrojanakul P, Sirangkapracha P, Leowattana W, Fucharoen S. Prevalence and clinical significance of hepatitis C virus infection in Thai patients with thalassemia. Int J Hematol 2003;78:374-378. [CrossRef]
3. Forget BG. Thalassemia syndromes. In: Hoffman R, Benz E J, Shathl S J, Furie B, Cohen HJ, Silberstein LE, Mcglare P, editors. Hematology Basic Principles and Practice. 3rd ed. Philadelphia: Churchill Livingstone, 2000:485-510.
4. Chevaliez S, Pawlotsky JM. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 2007;13:2461-2466.
5. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-51. [CrossRef]
6. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-2399. [CrossRef]
7. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan S-W, Chayama K. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatol 1994;19:1321-1324. [CrossRef]
8. Dixit V, Quan S, Martin P, Larson D, Brezina M, DiNello R, Sra K, Lau JY, Chien D, Kolberg J, et al. Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J Clin Microbiol 1995;33:2978-983.
9. Stuyver L, Vanarnhem W, Wyseur A, Hernandez F, Delaporte E, Maertens G. Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and non-structural 5B regions and identification of five additional subtypes. Proc Natl Acad Sci USA 1994;91:10134-10138. [CrossRef]
10. Maertens G, Stuyver L. Typing of hepatitis C virus isolates. In: Rizzetto M, Purcell RH, Gerin JL, Verme G, editors. Viral Hepatitis and Liver Disease. Turin: Minerva Medica, 1997:181-186.
11. Mahaney K, Tedeschi V, Maertens G, Bisceglie A, Vergalla J, Hoofnagle J, Sallie R. Genotypic analysis of hepatitis C virus in American patients. Hepatology 1994;20:1405-1414. [CrossRef]
12. Salwa B. Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping. J Med Microbiol 2002;51:700-704.
13. Dusheiko G, Schmilovitz H, Brown D. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatol 1994;19:13-18. [CrossRef]
14. Abdulkarim AS, Zein NN, Germer JJ. Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. Am J Trop Med Hyg 1998;59:571-576.
15. Davidson F, Simmonds P, Ferguson JC. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 59 non-coding region. J Gen Virol 1995;76:1197-1204. [CrossRef]
16. Li CK, Chan PK, Ling SC, Ha SY. Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major. Br J Haematol 2002;117:755-758. [CrossRef]
17. Marco V, Iacono L, Capra M, Grutta S, Ciaccio C, Gerardi C, Maggio A, Renda D, Almasio P, Pisa R, Craxi A. Alpha interferon treatment of chronic hepatitis C in beta-thalassaemia. Gut 1993;34 (2 Suppl):S142-S143.
18. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR. Complications of b-thalassemia major in North America. Blood 2004;104:34-39. [CrossRef]
19. Strader DB. Understudied populations with hepatitis C. Hepatology 2002;36:226-236. [CrossRef]
20. Distante S, Bjoro K, Hellum KB, Myrvang B, Berg JP, Skaug K. Raised serum ferritin predicts nonresponse to interferon and ribavirin treatment in patients with chronic hepatitis C infection. Liver 2002;22:269-275. [CrossRef]
21. Sharara AI, Ramia S, Ramlawi F, Fares JE, Klayme S, Naman R. Genotyping of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries. Epidemiol Infect 2007;135:427-432. [CrossRef]
22. Bdour S. Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping. J Med Microbiol 2002;51:700-704.
23. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ, Zand V, Azami AA, Hosseini MM, Faridi AR, Davari K, Hajibeigi B. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med 2006;9:319-323.